U-survival for prognostic prediction of disease progression and mortality of patients with COVID-19
Abstract The rapid increase of patients with coronavirus disease 2019 (COVID-19) has introduced major challenges to healthcare services worldwide. Therefore, fast and accurate clinical assessment of COVID-19 progression and mortality is vital for the management of COVID-19 patients. We developed an...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3d012675bb3543f6a9af28dbc3904e5e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3d012675bb3543f6a9af28dbc3904e5e |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3d012675bb3543f6a9af28dbc3904e5e2021-12-02T16:56:10ZU-survival for prognostic prediction of disease progression and mortality of patients with COVID-1910.1038/s41598-021-88591-z2045-2322https://doaj.org/article/3d012675bb3543f6a9af28dbc3904e5e2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-88591-zhttps://doaj.org/toc/2045-2322Abstract The rapid increase of patients with coronavirus disease 2019 (COVID-19) has introduced major challenges to healthcare services worldwide. Therefore, fast and accurate clinical assessment of COVID-19 progression and mortality is vital for the management of COVID-19 patients. We developed an automated image-based survival prediction model, called U-survival, which combines deep learning of chest CT images with the established survival analysis methodology of an elastic-net Cox survival model. In an evaluation of 383 COVID-19 positive patients from two hospitals, the prognostic bootstrap prediction performance of U-survival was significantly higher (P < 0.0001) than those of existing laboratory and image-based reference predictors both for COVID-19 progression (maximum concordance index: 91.6% [95% confidence interval 91.5, 91.7]) and for mortality (88.7% [88.6, 88.9]), and the separation between the Kaplan–Meier survival curves of patients stratified into low- and high-risk groups was largest for U-survival (P < 3 × 10–14). The results indicate that U-survival can be used to provide automated and objective prognostic predictions for the management of COVID-19 patients.Janne J. NäppiTomoki UemuraChinatsu WatariToru HironakaTohru KamiyaHiroyuki YoshidaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Janne J. Näppi Tomoki Uemura Chinatsu Watari Toru Hironaka Tohru Kamiya Hiroyuki Yoshida U-survival for prognostic prediction of disease progression and mortality of patients with COVID-19 |
description |
Abstract The rapid increase of patients with coronavirus disease 2019 (COVID-19) has introduced major challenges to healthcare services worldwide. Therefore, fast and accurate clinical assessment of COVID-19 progression and mortality is vital for the management of COVID-19 patients. We developed an automated image-based survival prediction model, called U-survival, which combines deep learning of chest CT images with the established survival analysis methodology of an elastic-net Cox survival model. In an evaluation of 383 COVID-19 positive patients from two hospitals, the prognostic bootstrap prediction performance of U-survival was significantly higher (P < 0.0001) than those of existing laboratory and image-based reference predictors both for COVID-19 progression (maximum concordance index: 91.6% [95% confidence interval 91.5, 91.7]) and for mortality (88.7% [88.6, 88.9]), and the separation between the Kaplan–Meier survival curves of patients stratified into low- and high-risk groups was largest for U-survival (P < 3 × 10–14). The results indicate that U-survival can be used to provide automated and objective prognostic predictions for the management of COVID-19 patients. |
format |
article |
author |
Janne J. Näppi Tomoki Uemura Chinatsu Watari Toru Hironaka Tohru Kamiya Hiroyuki Yoshida |
author_facet |
Janne J. Näppi Tomoki Uemura Chinatsu Watari Toru Hironaka Tohru Kamiya Hiroyuki Yoshida |
author_sort |
Janne J. Näppi |
title |
U-survival for prognostic prediction of disease progression and mortality of patients with COVID-19 |
title_short |
U-survival for prognostic prediction of disease progression and mortality of patients with COVID-19 |
title_full |
U-survival for prognostic prediction of disease progression and mortality of patients with COVID-19 |
title_fullStr |
U-survival for prognostic prediction of disease progression and mortality of patients with COVID-19 |
title_full_unstemmed |
U-survival for prognostic prediction of disease progression and mortality of patients with COVID-19 |
title_sort |
u-survival for prognostic prediction of disease progression and mortality of patients with covid-19 |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/3d012675bb3543f6a9af28dbc3904e5e |
work_keys_str_mv |
AT jannejnappi usurvivalforprognosticpredictionofdiseaseprogressionandmortalityofpatientswithcovid19 AT tomokiuemura usurvivalforprognosticpredictionofdiseaseprogressionandmortalityofpatientswithcovid19 AT chinatsuwatari usurvivalforprognosticpredictionofdiseaseprogressionandmortalityofpatientswithcovid19 AT toruhironaka usurvivalforprognosticpredictionofdiseaseprogressionandmortalityofpatientswithcovid19 AT tohrukamiya usurvivalforprognosticpredictionofdiseaseprogressionandmortalityofpatientswithcovid19 AT hiroyukiyoshida usurvivalforprognosticpredictionofdiseaseprogressionandmortalityofpatientswithcovid19 |
_version_ |
1718382794730635264 |